Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Morphological and chemical changes in Cd-free colloidal QD-LEDs during operation.

Science advances·2026

Same author

Evaluating the robustness and readiness of large frontier models in health AI applications.

Nature medicine·2026

Same author

Ambient-compatible precursor engineering for efficient perovskite photovoltaics.

Nature communications·2026

Same author

Extending the Weakly Confined Regime of Perovskite Nanocrystals for Fast Emission at Low Temperature.

ACS nano·2026

Same author

Multimodal AI generates virtual population for tumor microenvironment modeling.

Cell·2025

Same author

Oxygen Vacancy Formation in ZnSeTe Blue Quantum Dot Light-Emitting Diodes.

Journal of the American Chemical Society·2025

Search research articles

Related Experiment Video

Updated: May 23, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Multistage nanoparticles for improved delivery into tumor tissue.

Triantafyllos Stylianopoulos¹, Cliff Wong, Moungi G Bawendi

¹Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.

Methods in Enzymology

|March 28, 2012

Summary

This study introduces a novel shrinking nanoparticle system designed to overcome tumor microenvironment barriers. This approach aims to improve drug delivery for enhanced cancer detection and treatment, leading to better therapeutic outcomes.

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Related Experiment Videos

Last Updated: May 23, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Area of Science:

Biomedical Engineering
Nanotechnology
Oncology

Background:

The enhanced permeability and retention (EPR) effect is crucial for nanoscale drug delivery to solid tumors.
Tumor microenvironment barriers limit homogeneous nanomedicine delivery, hindering effective cancer treatment.
Overcoming these barriers is essential to improve nanotherapeutic efficacy and patient outcomes.

Purpose of the Study:

To develop a novel multistage nanoparticle system for improved and uniform delivery of nanotherapeutics within solid tumors.
To design nanoparticles that shrink upon entering the tumor interstitial space to optimize intratumoral distribution.
To provide detailed methods for characterizing these advanced nanoparticles.

Main Methods:

Synthesis of a novel multistage nanoparticle formulation.
Characterization of nanoparticle size changes within the tumor microenvironment.
Evaluation of nanoparticle delivery and distribution within tumors.

Main Results:

The developed nanoparticles shrink in size within the tumor interstitial space.
This size reduction facilitates optimized delivery and distribution of nanotherapeutics.
The study provides comprehensive experimental methods for nanoparticle characterization.

Conclusions:

The novel shrinking nanoparticle system effectively addresses tumor microenvironment barriers.
This approach promises enhanced delivery and efficacy of nanotherapeutics for cancer treatment.
Further development of such systems could significantly improve cancer patient outcomes.